{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-26-000232","form_type":"8-K","ticker":"TENX","cik":"0000034956","company_name":"TENAX THERAPEUTICS, INC.","filed_at":"2026-01-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.370037+00:00","generated_at":"2026-05-16T11:07:31.677115+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Tenax CMO Dr. Stuart Rich moves to 4-day work week; salary prorated 80%","bullets":["Effective Jan 1, 2026, Dr. Rich will average 4 days per week as CMO.","Annual base salary prorated to 80% (80% of prior salary) reflecting reduced schedule.","Board approved amendment on Dec 22, 2025; executed Jan 6, 2026.","Executive acknowledges voluntary consent and no 'Good Reason' for termination."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-26-000232","json":"https://secwatch.observer/filing/0001654954-26-000232.json","markdown":"https://secwatch.observer/filing/0001654954-26-000232.md","text":"https://secwatch.observer/filing/0001654954-26-000232.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/34956/000165495426000232/0001654954-26-000232-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/34956/000165495426000232/tennx_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T11:07:31.677115+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}